TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vaccinova AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
69,166
|
37,751
|
27,127 |
Financial expenses |
15
|
24
|
12 |
Earnings before taxes |
7,097
|
-589
|
638 |
EBITDA |
7,323
|
-408
|
746 |
Total assets |
13,852
|
5,838
|
4,878 |
Current assets |
12,843
|
5,125
|
4,415 |
Current liabilities |
6,501
|
4,116
|
2,532 |
Equity capital |
7,311
|
1,704
|
2,191 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
35
|
25
|
20 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
52.8%
|
29.2%
|
44.9% |
Turnover per employee |
1,976
|
1,510
|
1,356 |
Profit as a percentage of turnover |
10.3%
|
-1.6%
|
2.4% |
Return on assets (ROA) |
51.3%
|
-9.7%
|
13.3% |
Current ratio |
197.6%
|
124.5%
|
174.4% |
Return on equity (ROE) |
97.1%
|
-34.6%
|
29.1% |
Change turnover |
31,415
|
10,624
|
15,088 |
Change turnover % |
83%
|
39%
|
125% |
Chg. No. of employees |
10
|
5
|
15 |
Chg. No. of employees % |
40%
|
25%
|
300% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.